Anderson Raymond
Related Filers (3)
- Raptor Pharmaceutical Corp (32)
- Monopar Therapeutics (21)
- RAPTOR PHARMACEUTICALS CORP. (4)
- Show More ...
Ownership (57)
4
Wednesday, 1/3/2024
Monopar Therapeutics: Statement of changes in beneficial ownership of securities
4
Tuesday, 10/3/2023
Monopar Therapeutics: Statement of changes in beneficial ownership of securities
4
Monday, 7/3/2023
Monopar Therapeutics: Statement of changes in beneficial ownership of securities
4
Tuesday, 4/4/2023
Monopar Therapeutics: Statement of changes in beneficial ownership of securities
4
Friday, 2/3/2023
Monopar Therapeutics: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/3/2023
Monopar Therapeutics: Statement of changes in beneficial ownership of securities
4
Monday, 10/3/2022
Monopar Therapeutics: Statement of changes in beneficial ownership of securities
4
Friday, 7/1/2022
Monopar Therapeutics: Statement of changes in beneficial ownership of securities
4
Friday, 4/1/2022
Monopar Therapeutics: Statement of changes in beneficial ownership of securities
4
Friday, 2/4/2022
Monopar Therapeutics: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/4/2022
Monopar Therapeutics: Statement of changes in beneficial ownership of securities
4
Friday, 10/1/2021
Monopar Therapeutics: Statement of changes in beneficial ownership of securities
4
Friday, 7/2/2021
Monopar Therapeutics: Statement of changes in beneficial ownership of securities
4
Thursday, 4/1/2021
Monopar Therapeutics: Statement of changes in beneficial ownership of securities
4
Thursday, 1/28/2021
Monopar Therapeutics: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/5/2021
Monopar Therapeutics: Statement of changes in beneficial ownership of securities
4
Thursday, 7/2/2020
Monopar Therapeutics: Statement of changes in beneficial ownership of securities
4
Wednesday, 4/1/2020
Monopar Therapeutics: Statement of changes in beneficial ownership of securities
4
Thursday, 2/20/2020
Monopar Therapeutics: Statement of changes in beneficial ownership of securities
4
Thursday, 9/27/2018
Monopar Therapeutics: Statement of changes in beneficial ownership of securities
3
Monday, 1/8/2018
Monopar Therapeutics: Initial statement of beneficial ownership of securities
4
Wednesday, 10/26/2016
Raptor Pharmaceutical Corp: Statement of changes in beneficial ownership of securities
4
Monday, 6/27/2016
Raptor Pharmaceutical Corp: Statement of changes in beneficial ownership of securities
4
Friday, 9/4/2015
Raptor Pharmaceutical Corp: Statement of changes in beneficial ownership of securities
4
Wednesday, 9/2/2015
Raptor Pharmaceutical Corp: Statement of changes in beneficial ownership of securities
4
Thursday, 5/21/2015
Raptor Pharmaceutical Corp: Statement of changes in beneficial ownership of securities
4
Thursday, 3/26/2015
Raptor Pharmaceutical Corp: Statement of changes in beneficial ownership of securities
4
Wednesday, 2/11/2015
Raptor Pharmaceutical Corp: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/14/2015
Raptor Pharmaceutical Corp: Statement of changes in beneficial ownership of securities
4
Friday, 9/12/2014
Raptor Pharmaceutical Corp: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/9/2014
Raptor Pharmaceutical Corp: Statement of changes in beneficial ownership of securities
4
Tuesday, 3/11/2014
Raptor Pharmaceutical Corp: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/11/2014
Raptor Pharmaceutical Corp: Statement of changes in beneficial ownership of securities
4
Thursday, 1/9/2014
Raptor Pharmaceutical Corp: Statement of changes in beneficial ownership of securities
4
Tuesday, 11/12/2013
Raptor Pharmaceutical Corp: Statement of changes in beneficial ownership of securities
4
Wednesday, 9/11/2013
Raptor Pharmaceutical Corp: Statement of changes in beneficial ownership of securities
4
Monday, 12/31/2012
Raptor Pharmaceutical Corp: Statement of changes in beneficial ownership of securities
4
Monday, 10/1/2012
Raptor Pharmaceutical Corp: Statement of changes in beneficial ownership of securities
4
Thursday, 9/27/2012
Raptor Pharmaceutical Corp: Statement of changes in beneficial ownership of securities
4
Friday, 9/14/2012
Raptor Pharmaceutical Corp: Statement of changes in beneficial ownership of securities
4
Monday, 6/11/2012
Raptor Pharmaceutical Corp: Statement of changes in beneficial ownership of securities
4
Monday, 6/11/2012
Raptor Pharmaceutical Corp: Statement of changes in beneficial ownership of securities
4/A
Wednesday, 5/9/2012
Raptor Pharmaceutical Corp: Statement of changes in beneficial ownership of securities
4
Wednesday, 4/4/2012
Raptor Pharmaceutical Corp: Statement of changes in beneficial ownership of securities
4
Thursday, 3/1/2012
Raptor Pharmaceutical Corp: Statement of changes in beneficial ownership of securities
4
Monday, 9/26/2011
Raptor Pharmaceutical Corp: Statement of changes in beneficial ownership of securities
4/A
Friday, 2/18/2011
Raptor Pharmaceutical Corp: Statement of changes in beneficial ownership of securities
4
Tuesday, 11/23/2010
Raptor Pharmaceutical Corp: Statement of changes in beneficial ownership of securities
4
Wednesday, 10/13/2010
Raptor Pharmaceutical Corp: Statement of changes in beneficial ownership of securities
4
Thursday, 3/11/2010
Raptor Pharmaceutical Corp: Statement of changes in beneficial ownership of securities
3/A
Friday, 10/9/2009
Raptor Pharmaceutical Corp: Initial statement of beneficial ownership of securities
3
Thursday, 10/1/2009
Raptor Pharmaceutical Corp: Initial statement of beneficial ownership of securities
4
Thursday, 10/1/2009
Raptor Pharmaceutical Corp: Statement of changes in beneficial ownership of securities
4
Thursday, 10/1/2009
RAPTOR PHARMACEUTICALS CORP.: Statement of changes in beneficial ownership of securities
4
Monday, 6/18/2007
RAPTOR PHARMACEUTICALS CORP.: Statement of changes in beneficial ownership of securities
3
Wednesday, 5/31/2006
HIGHLAND CLAN CREATIONS CORP.: Initial statement of beneficial ownership of securities
4
Wednesday, 5/31/2006
HIGHLAND CLAN CREATIONS CORP.: Statement of changes in beneficial ownership of securities